Devin Whittemore Smith

Devin Whittemore Smith (senior executive) discloses dealings in 2 companies, chiefly Kineta, Inc./de and IO Biotech, Inc. Between 1 December 2021 and 23 December 2024, the trades on record add up to 5 filings.

The open-market side counts 1 purchase for €9,317 alongside 2 sales for €8,253. Netting one side against the other leaves €1,064 of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. So far in 2024, the count stands at 1 purchase and no sales.

On 23 December 2024 came the latest disclosure, an open-market purchase for €9,317 in IO Biotech, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.